Acrux Overview

  • Founded
  • 1998
Founded
  • Status
  • Public
  • Employees
  • 36
Employees
  • Stock Symbol
  • ACR
Stock Symbol
  • Share Price
  • $0.12
  • (As of Friday Closing)

Acrux General Information

Description

Acrux Ltd is an Australian pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. Its products include Testosterone Solution, Estradiol MDTS and others. It also has some of its products under the pipeline. Geographically, it has a presence in Australia; Germany; United States, and other countries. It generates maximum revenue from the Lenzetto product.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Biotechnology
Stock Exchange
ASX
Primary Office
  • 103-113 Stanley Street
  • West Melbourne, Victoria 3003
  • Australia
+61 (03) 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Acrux Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.12 $0.11 $0.06 - $0.17 $19.4M 169M 165K -$0.04

Acrux Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 12,121 12,121 5,920 (7,506)
Revenue 840 840 451 2,081
EBITDA (5,961) (5,961) (6,069) (12,532)
Net Income (6,349) (6,349) (5,953) (10,985)
Total Assets 12,255 12,255 17,111 23,867
Total Debt 1,650 1,650 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Acrux Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Acrux‘s full profile, request access.

Request a free trial

Acrux Executive Team (2)

Name Title Board Seat Contact Info
Michael Kotsanis Chief Executive Officer, Managing Director & Board Member
Deborah Ambrosini Chief Financial Officer & Company Secretary
To view Acrux’s complete executive team members history, request access »

Acrux Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial